Syndax Pharmaceuticals, Inc. Share Price

Syndax Pharmaceuticals, Inc. Share Price

NASDAQ: SNDX | Small Cap
$14.18
-$0.15 (-1.05%) Last updated on 29 Oct, 2026 | 20:40 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Syndax Pharmaceuticals, Inc. Stock Performance

Open
$14.48
Prev. Close
$14.33
Circuit Range
N/A
Day Range
$14.10 - $14.65
Year Range
$12.79 - $25.58
Volume
40,727
Average Traded
$14.30

Syndax Pharmaceuticals, Inc. Share Price Today

As of 29 October 2026, Syndax Pharmaceuticals, Inc.'s share price is $14.18. The stock opened at $14.48, compared to its previous close of $14.33. During today's trading session, Syndax Pharmaceuticals, Inc.'s share price traded between $14.10 and $14.65, with an average price of $14.38. Over the past 52 weeks, the stock has recorded a high of $25.58 and a low of $12.79. In terms of performance, Syndax Pharmaceuticals, Inc.'s share price has declined by 34.00% over the last six months and is up 3.50% on a year-on-year basis.

Syndax Pharmaceuticals, Inc. Share Price Chart

Line chart of the Syndax Pharmaceuticals, Inc. price trend over the selected period. The price fell overall, ranging from 14.10 to 14.65, ending at 14.18.
$14.10$14.65
L
Show Current Price
H

Syndax Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Market Cap
$1.23B
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-2.47
Revenue (TTM)
$172.35B
Return On Equity (TTM)
-1462.12%
Profit Margin
-165.60%
Debt to Equity
39.00
Quarterly Earnings Growth YoY
18.71%

Syndax Pharmaceuticals, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$45.87$68.73$64.86$72.79
Net Profit-$60.72-$68.01-$42.67-$49.36
Net Profit Margin-132.37%-98.95%-65.79%-67.81%
Income ChangeN/A-12.01%37.26%-15.68%

Syndax Pharmaceuticals, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$23.68$172.35
Net Profit-$149.34-$209.36-$318.76-$285.42
Net Profit MarginN/AN/A-1346.11%-165.60%
Income ChangeN/A-40.19%-52.25%10.46%

About Syndax Pharmaceuticals, Inc.

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. Its product candidates include revumenib and axatilimab. It is developing revumenib, a selective menin-MLL inhibitor for KMT2A-rearranged (MLL-r) and NPM1-mutant acute leukemias, including ALL and AML. It is also developing axatilimab, a CSF-1R-blocking antibody for cGVHD and idiopathic pulmonary fibrosis. Entinostat is its oral, small molecule product candidate that has direct effects on both cancer cells and immune regulatory cells. The business activity of the group is functioned through the region of the United States.

Syndax Pharmaceuticals, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$18.46
$14.18
-24.79%
Sep 2026
$19.58
$18.86
-6.43%
Aug 2026
$19.09
$20.15
+5.86%
Jul 2026
$22.06
$19.04
-12.84%
Jun 2026
$19.30
$21.84
+11.49%
May 2026
$20.98
$19.59
-8.82%
Apr 2026
$23.85
$21.48
-8.07%
Mar 2026
$21.63
$23.37
+7.60%
Feb 2026
$20.45
$21.72
+6.84%
Jan 2026
$21.18
$20.33
-3.28%
Dec 2025
$19.71
$21.02
+5.95%
Nov 2025
$13.67
$19.84
+44.82%

SNDX Share Price FAQs